A5076426417- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Venous Thromboembolism Diagnosis and Management
- Infective Endocarditis Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- COVID-19 and healthcare impacts
- Cardiovascular and Diving-Related Complications
- Traumatic Brain Injury and Neurovascular Disturbances
- Blood Pressure and Hypertension Studies
- Acute Ischemic Stroke Management
- HIV-related health complications and treatments
- Cardiac Arrhythmias and Treatments
- Cardiac Imaging and Diagnostics
- Cardiac Valve Diseases and Treatments
- Peripheral Artery Disease Management
- Cardiovascular Health and Disease Prevention
- Hepatitis C virus research
- Pulmonary Hypertension Research and Treatments
- Liver Disease Diagnosis and Treatment
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Respiratory Support and Mechanisms
- Streptococcal Infections and Treatments
- Hormonal Regulation and Hypertension
- Antimicrobial Resistance in Staphylococcus
Jacobi Medical Center
2015-2025
Albert Einstein College of Medicine
2018-2025
New York City Health and Hospitals Corporation
2022-2025
Brown University
2025
Montefiore Medical Center
2018-2024
The Bronx Defenders
2020-2024
City University of New York
2022-2023
CUNY School of Law
2022-2023
Newark Beth Israel Medical Center
2022
Aristotle University of Thessaloniki
2019-2021
ObjectiveTo explore the possible associations of serum 25-hydroxyvitamin D [25(OH)D] concentration with coronavirus disease 2019 (COVID-19) in-hospital mortality and need for invasive mechanical ventilation.Patients MethodsA retrospective, observational, cohort study was conducted at 2 tertiary academic medical centers in Boston New York. Eligible participants were hospitalized adult patients laboratory-confirmed COVID-19 between February 1, 2020, May 15, 2020. Demographic clinical...
BACKGROUND Corticosteroids may be beneficial in a subset of patients with coronavirus disease 2019 (COVID‐19), but predictors therapeutic response remain unknown. C‐reactive protein (CRP) is routinely measured biomarker, and reduction its levels after initiation therapy predict inpatient mortality. METHODS In this retrospective cohort study, the charts who were admitted to Montefiore Medical Center between March 10, 2020, May 2, 2020 for management COVID‐19 examined. Of all met inclusion...
Previous studies have unveiled a relationship between the severity of coronavirus disease 2019 (COVID-19) pneumonia and obesity. The aims this multicenter retrospective cohort study were to disentangle association BMI associated metabolic risk factors (diabetes, hypertension, hyperlipidemia, current smoking status) in critically ill patients with COVID-19. Patients admitted intensive care units for COVID-19 21 centers (in Europe, Israel, United States) enrolled February 19, 2020, May 2020....
Obesity is a recognized risk factor for heart failure (HF) in people living with HIV. However, among patients HF, being overweight or having mild to moderate obesity has been associated significantly improved survival rates compared those at normal weight-a phenomenon known as the paradox. This paradox not yet evaluated both HIV and HF era of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) sodium-glucose cotransporter-2 inhibitors (SGLT-2is). Our study aimed assess mortality body mass...
Background: Takotsubo Syndrome (TTS) is a transient left ventricular systolic dysfunction typically characterized by anteroseptal-apical dyskinetic ballooning of the ventricle with hyperkinetic base, without significant obstructive coronary artery disease. The interplay between systemic inflammation and hemodynamic stress in sepsis exacerbates susceptibility to TTS. We aim investigate characteristics factors associated TTS critically ill patients admitted intensive care unit. Methods: A...
It has been demonstrated that obesity is an independent risk factor for worse outcomes in patients with COVID-19. Our objectives were to investigate which classes of are associated higher in-hospital mortality and assess the association between systemic inflammation. This was a retrospective study included consecutive hospitalized COVID-19 tertiary center. Three thousand five hundred thirty this analysis (female sex: 1579, median age: 65 years). The body mass index (BMI) 28.8 kg/m2. In...
Severe obesity increases the risk for negative outcomes in patients with coronavirus disease 2019 (COVID-19). Our objectives were to investigate effect of BMI on in-hospital our New York City Health and Hospitals' ethnically diverse population, further explore this by age, sex, race/ethnicity, timing admission, and, given relationship between COVID-19 hyperinflammation, assess concentrations markers systemic inflammation different groups. A retrospective study was conducted hospitalized...